BREAST CANCER CARE & RESEARCH FUND (EIN 330839993) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Phone

3109277606

Tax Period

2024-01-01 to 2024-12-31

BREAST CANCER CARE & RESEARCH FUND, founded in 1998, is a micro nonprofit in the Medical Research sector that reported $23K in total revenue in fiscal year 2024. Revenue fell 52% from the prior year — a significant decline worth monitoring. Expenses of $27K exceeded revenue, resulting in a 20% operating deficit.

Mission

Breast Cancer Care & Research Funds mission is to eradicate breast cancer through education, research, advocacy and community outreach.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $22,765

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $22,765

Expense Breakdown

Grants Paid $4,250

Salaries & Benefits $6,334

Fundraising Expenses $0

Program Expenses $21,925

Other Expenses $16,825

TOTAL EXPENSES $27,409

Year-over-Year Comparison

	2024	2023	Change
Revenue	$22,765	$47,820	-0.5%
Expenses	$27,409	$28,185	0.0%
Net Income	$-4,644	$19,635	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michele Rakoff	Executive Director	40.00	Director	$0	$0	$0
Kim Tankersley	Education Communicator	1.00	Director	$0	$0	$0
Melanie Canter	Treasurer	1.00	Officer Director	$0	$0	$0
Barbora Stankova	International Advocate	1.00	Director	$0	$0	$0
Michele Atlan	Secretary	1.00	Officer Director	$0	$0	$0
Lori Petitti	President	1.00	Officer Director	$0	$0	$0
Mayra Serrano	Vice President	1.00	Officer Director	$0	$0	$0
Karren Ganstwig	Public Policy	1.00	Director	$0	$0	$0
Shirley Brown	Community Engagement	1.00	Director	$0	$0	$0
Deborah Romer	Research	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$22,765	$27,409	$141,169	$-4,644
2023	$47,820	$28,185	$145,808	$19,635
2022	$34,808	$42,325	$127,884	$-7,517
2021	$37,345	$30,900	$134,193	$6,445
2020	$41,330	$22,414	$103,828	$18,916
2020	$66,663	$22,414	$129,161	$44,249
2019	$60,291	$24,115	$83,841	$36,176
2018	$27,352	$20,875	$47,324	$6,477

BREAST CANCER CARE & RESEARCH FUND